Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies

Get started →

Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

9326

1

Gryphon Digital Mining, Inc. Gryphon Digital Mining Reports Decline in Revenues, Net Loss in Q3 2024, Despite Revenue Growth for Nine-Month Period

Via official filing (AI summary) | 6 months ago | 0 comments

9327

1

Bancorp 34, Inc. Bancorp 34 Reports Significant Growth in Financial Performance Following CBOA Merger

Via official filing (AI summary) | 6 months ago | 0 comments

9328

1

ALLURION TECHNOLOGIES, INC. Allurion Technologies Reports 71% Revenue Decline, Net Loss Improvement in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9329

1

Loar Holdings Inc. Loar Holdings Reports 25% Revenue Growth, Net Income Turnaround in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9330

1

SONIDA SENIOR LIVING, INC. Sonida Senior Living Reports 15.8% Revenue Growth, Net Income Turnaround in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9331

1

New Concept Energy, Inc. New Concept Energy Reports Mixed Financial Results for Q3 and Nine Months Ended September 30, 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9332

1

Channel Therapeutics Corp Chromocell Therapeutics Reports Significant Asset Growth, Improved Cash Position, and Increased Operating Expenses

Via official filing (AI summary) | 6 months ago | 0 comments

9333

1

PERPETUA RESOURCES CORP. Perpetua Resources Reports Financial Developments, Appoints New CEO, and Advances Stibnite Gold Project

Via official filing (AI summary) | 6 months ago | 0 comments

9334

1

SBC Medical Group Holdings Inc SBC Medical Group Holdings Reports 12% Revenue Growth, Net Income Decline in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

9335

1

Esquire Financial Holdings, Inc. Esquire Financial Holdings Reports 10.2% Asset Growth, 21.9% Interest Income Increase in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

9336

1

Broad Street Realty, Inc. Broad Street Realty Reports Mixed Q3 Results, Net Loss Increases 23%

Via official filing (AI summary) | 6 months ago | 0 comments

9337

1

Kraig Biocraft Laboratories, Inc Kraig Biocraft Laboratories Reports Significant Financial Challenges, Net Loss Increases

Via official filing (AI summary) | 6 months ago | 0 comments

9338

1

CFSB Bancorp, Inc. /MA/ CFSB Bancorp Reports Net Loss of $6,000 in Q3 2024, Down from Net Income of $123,000 in Q3 2023

Via official filing (AI summary) | 6 months ago | 0 comments

9339

1

EMPIRE PETROLEUM CORP Empire Petroleum Corporation Reports Revenue Growth, Increased Losses, and Liquidity Challenges in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9340

1

Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals Reports Improved Net Loss, Reduced Operating Expenses in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9341

1

SRM Entertainment, Inc. SRM Entertainment Reports Mixed Financial Results, Net Loss, and Strategic Acquisitions

Via official filing (AI summary) | 6 months ago | 0 comments

9342

1

Pasithea Therapeutics Corp. Pasithea Therapeutics Reports Mixed Financial Results, Decrease in Cash Reserves, and Strategic Developments

Via official filing (AI summary) | 6 months ago | 0 comments

9343

1

5E Advanced Materials, Inc. 5E Advanced Materials Reports Net Loss of $12.9M, Cash Position Improves Amid Operational Challenges

Via official filing (AI summary) | 6 months ago | 0 comments

9344

1

4D Molecular Therapeutics, Inc. 4D Molecular Therapeutics Reports Significant Financial Decline, Net Loss in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9345

1

Viracta Therapeutics, Inc. Viracta Therapeutics Reports Financial Developments, Seeks Additional Funding Amid Ongoing Net Losses

Via official filing (AI summary) | 6 months ago | 0 comments

9346

1

Roadzen Inc. Roadzen Inc. Reports 23% Revenue Decline, Significant Increase in Costs and Losses in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

9347

1

Provident Bancorp, Inc. /MD/ Provident Bancorp Reports 71% Decline in Net Income, Strategic Shifts in Lending Practices

Via official filing (AI summary) | 6 months ago | 0 comments

9348

1

QUICKLOGIC Corp QuickLogic Reports 36% Revenue Decline in Q3, Net Loss of $2.1M, Amid Increased Investment in Product Development

Via official filing (AI summary) | 6 months ago | 0 comments

9349

1

Ashford Inc. Ashford Inc. Reports Mixed Q3 2024 Results with 5.5% Revenue Growth and Net Loss

Via official filing (AI summary) | 6 months ago | 0 comments

9350

1

Kyverna Therapeutics, Inc. Kyverna Therapeutics Reports Significant Financial Developments, Including Increased Cash Reserves and Operating Expenses

Via official filing (AI summary) | 6 months ago | 0 comments